Table 1.

Up-regulated pathways by imatinib.

Direction	GAGE Analysis: IMATINIB vs. CONTROL	Statistic	Genes	Adj. p-Value
Up	Focal adhesion	4.28	168	3.8 × 10−3
	PI3K-Akt signaling pathway	3.8134	257	1.2 × 10−2
	Human cytomegalovirus infection	3.5472	153	2.3 × 10−2
	Tight junction	3.4354	128	2.4 × 10−2
	Human papillomavirus infection	3.3749	259	2.4 × 10−2
	Pathways in cancer	3.3199	408	2.4 × 10−2
	Salmonella infection	3.246	208	2.6 × 10−2
	Prostate cancer	3.2287	82	2.6 × 10−2
	Cytokine-cytokine receptor interaction	3.2113	103	2.6 × 10−2
	Kaposi sarcoma-associated herpesvirus infection	3.1396	133	2.6 × 10−2
	Amyotrophic lateral sclerosis	3.1259	299	2.6 × 10−2
	Regulation of actin cytoskeleton	3.1104	166	2.6 × 10−2
	Hepatitis C	3.0765	114	2.8 × 10−2
	Alzheimer disease	2.9958	311	3.2 × 10−2
	JAK-STAT signaling pathway	2.9416	84	3.6 × 10−2
	Leukocyte transendothelial migration	2.9201	83	3.6 × 10−2
	Ras signaling pathway	2.8883	166	3.6 × 10−2
	Prion disease	2.8792	213	3.6 × 10−2
	Small cell lung cancer	2.7779	84	4.7 × 10−2
	Proteoglycans in cancer	2.7667	170	4.7 × 10−2